In focus · trending topic

hyperkalemia

2 stories · following the connections

Relypsa Announces FDA Approval of Supplemental New Drug Application to Enable the Usage of Veltassa® (patiromer) With or Without Food

By Nasdaq OMXMay 8, 2018, 12:01 PM UTC

Relypsa Presents Patiromer Clinical Trial Data on Serum Potassium in Patients with Hyperkalemia at the National Kidney Foundation 2018 Spring Clinical Meetings

By Nasdaq OMXApr 11, 2018, 12:01 PM UTC